BiotechTube
Kinamed

Kinamed

Camarillo, United States· Est.
kinamed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

Kinamed is a mature, commercial-stage medical device company with a diversified portfolio of niche orthopedic and surgical products. Its flagship technologies include the SuperCable polymer cerclage system, designed to eliminate metal debris, and the CarboJet CO2 bone preparation system for improving cement fixation in arthroplasty. The company maintains a steady commercial presence, supported by clinical studies and regular attendance at major surgical conferences, indicating an established revenue-generating business focused on surgeon adoption and procedural improvement.

OrthopedicsCardiothoracic SurgeryNeurosurgery

Technology Platform

Focused engineering solutions in polymer science (Iso-Elastic polymer cables) and surgical technique augmentation (CO2 bone preparation, patient-matched implants, surgical navigation).

Funding History

2
Total raised:$20M
Debt$5M
Series A$15M

Opportunities

The aging global population drives growth in joint arthroplasty and fracture repair, creating demand for durable solutions that reduce revision rates.
Kinamed's metal-free polymer cables and enhanced cement fixation technology directly address known complications, positioning them well in value-based care models.
Expansion into adjacent surgical specialties like cardiothoracic and neurosurgery provides additional revenue streams.

Risk Factors

Kinamed faces intense competition from large orthopedic conglomerates with greater sales and marketing resources.
Surgeon adoption of new techniques can be slow, and hospital reimbursement decisions may not fully recognize the value of its premium technologies.
The company's growth is dependent on continuous clinical validation and navigating complex hospital procurement processes.

Competitive Landscape

Kinamed competes in niche segments against giants like Stryker, Zimmer Biomet, and Johnson & Johnson's DePuy Synthes. Its competitive advantage lies in specialized, differentiated products (polymer cables, CO2 bone prep) rather than broad portfolios. It also competes with other smaller, innovative device companies and must constantly prove superior clinical utility to justify switching costs for surgeons and hospitals.

More companies in Drug Delivery & Formulation →More companies in United States →